Neumora’s KOASTAL-1 study results show navacaprant missed key goals in major depressive disorder. Additional studies and updates are anticipated.
Neumora Therapeutics Depression Drug Fails In First Of Three Pivotal Phase 3 Trials
Where Today's News Shapes Tomorrow
